Affinity Biosciences
Business Services · 1-10 Employees
View Company Info for Free
Overview
Phone Number
+61 397635445Website
affinity.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Affinity Biosciences
Affinity is an antibody discovery business normally focussed on discovering novel cancer therapeutics. In March, with the COVID-19 pandemic gaining momentum Affinity pivoted to screen its proprietary library of one hundred billion human antibodies to discover those that might neutralise SARS-CoV-2, the virus that causes COVID-19. After a number of successful campaigns conducted in parallel, Affinity discovered a number of antibodies that are highly effective in neutralising the infectivity of SARS-CoV-2 in the laboratory. Affinity is working with renowned international and Australian academics and institutes to move the program forward as rapidly as possible.Explore more
Popular SearchesAffinity Biosciences Pty LtdMyrio Therapeutics Pty LtdAffinity BiosciencesAffinity BIOAffinity Biosciences International Pty LtdSIC Code 87,873NAICS Code 54,541Show moreAffinity Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Affinity Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Affinity Biosciences has new funding data
Earning: See what the market has to say on Affinity Biosciences recently announced quarterly report
Click to see if Affinity Biosciences had a recent Job posting/layoffs
Product Launch: Get notified when Affinity Biosciences launches new products
Check if Affinity Biosciences has recently received funding, and reach out quickly before it becomes old news!
Affinity Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Affinity Biosciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Affinity Biosciences is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Affinity Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Affinity Biosciences
Compare insights from companies similar to Affinity Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Affinity Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Affinity Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Affinity Biosciences.
Affinity Biosciences Tech Stack
A closer look at the technologies used by Affinity Biosciences
See more technologies
Affinity Biosciences News & Media
Affinity discovers potent SARS-CoV-2 antibodies
MELBOURNE, Australia, July 2, 2020 /PRNewswire/ -- Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for cancer therapeutics, today announces the discovery of potent antibodies with therapeutic potential against COVID-19. In...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Affinity Biosciences
Sign Up For FreeTo access detailed company insights
Affinity is an antibody discovery business normally focussed on discovering novel cancer therapeutics. In March, with the COVID-19 pandemic gaining momentum Affinity pivoted to screen its proprietary library of one hundred billion human antibodies to discover those that might neutralise SARS-CoV-2, the virus that causes COVID-19. After a number of... Read More
